Bank of America – Merrill Lynch upgraded its rating on shares of Celgene Corp. (CELG: Quote) Tuesday to “Buy” from “Neutral.”
Celgene broke out around 10:30AM Tuesday and extended its gains late in the afternoon. The stock ended the session higher by 1.72 at $99.39. Celgene rose to its seventh consecutive new high for the year.
Click here to receive FREE breaking news email alerts for Celgene Corporation and others in your portfolio
by RTT Staff Writer
For comments and feedback: editorial@rttnews.comBusiness News